D L Sprecher

Author PubWeight™ 49.47‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 2001 3.74
2 Effect of hydroxymethylglutaryl coenzyme a reductase inhibitors on the progression of calcific aortic stenosis. Circulation 2001 2.17
3 Cardiovascular features of homozygous familial hypercholesterolemia: analysis of 16 patients. Am J Cardiol 1984 1.99
4 Association of body fat distribution and cardiovascular risk factors in children and adolescents. Circulation 1999 1.87
5 Overweight, fat patterning, and cardiovascular disease risk factors in black and white girls: The National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 1999 1.60
6 Hyperlipidemia and pancreatitis during pregnancy in two sisters with a mutation in the lipoprotein lipase gene. Ann Intern Med 1996 1.56
7 Overweight, fat patterning, and cardiovascular disease risk factors in black and white boys. J Pediatr 1999 1.41
8 Reduction of LDL cholesterol by 25% to 60% in patients with primary hypercholesterolemia by atorvastatin, a new HMG-CoA reductase inhibitor. Arterioscler Thromb Vasc Biol 1995 1.31
9 Apolipoprotein C-II deficiency syndrome. Clinical features, lipoprotein characterization, lipase activity, and correction of hypertriglyceridemia after apolipoprotein C-II administration in two affected patients. J Clin Invest 1986 1.28
10 Sexual maturation and obesity in 9- and 10-year-old black and white girls: the National Heart, Lung, and Blood Institute Growth and Health Study. J Pediatr 1994 1.26
11 The association of LDL receptor activity, LDL cholesterol level, and clinical course in homozygous familial hypercholesterolemia. Metabolism 1985 1.23
12 Effectiveness of once-nightly dosing of extended-release niacin alone and in combination for hypercholesterolemia. Am J Cardiol 1998 1.18
13 Two-dimensional electrophoresis of human plasma apolipoproteins. Clin Chem 1984 1.17
14 Accumulation of apolipoprotein E-rich high density lipoproteins in hyperalphalipoproteinemic human subjects with plasma cholesteryl ester transfer protein deficiency. J Clin Invest 1990 1.16
15 Isolevuglandin-protein adducts in humans: products of free radical-induced lipid oxidation through the isoprostane pathway. Biochim Biophys Acta 2000 1.07
16 Cardiac rehabilitation participation patterns in a large, tertiary care center: evidence for selection bias. J Cardiopulm Rehabil 2000 1.02
17 Evidence for an association between dehydroepiandrosterone sulfate and nonfatal, premature myocardial infarction in males. Circulation 1994 0.97
18 Analysis of the apoC-II gene in apoC-II deficient patients. Biochem Biophys Res Commun 1984 0.94
19 Homocysteine and lipoprotein(a) interact to increase CAD risk in young men and women. Arterioscler Thromb Vasc Biol 2000 0.93
20 Characterization of plasma lipoproteins in patients heterozygous for human plasma cholesteryl ester transfer protein (CETP) deficiency: plasma CETP regulates high-density lipoprotein concentration and composition. Metabolism 1991 0.93
21 Sex and race differences in cardiovascular disease risk factor changes in schoolchildren, 1975-1990: the Princeton School Study. Am J Public Health 1999 0.92
22 Serum glutathione in adolescent males predicts parental coronary heart disease. Circulation 1999 0.91
23 Human preproapolipoprotein C-II. Analysis of major plasma isoforms. J Biol Chem 1986 0.89
24 Apolipoprotein E-1Harrisburg: a new variant of apolipoprotein E dominantly associated with type III hyperlipoproteinemia. Biochim Biophys Acta 1989 0.88
25 Estimation of VLDL cholesterol in hyperlipidemia. Clin Chim Acta 1985 0.87
26 In vitro color flow, pulsed and continuous wave Doppler ultrasound masking of flow by prosthetic valves. J Am Coll Cardiol 1987 0.86
27 Definition and application of the discretionary screening indicators according to the National Cholesterol Education Program for Children and Adolescents. J Pediatr 1995 0.86
28 HDL cholesterol level predicts survival in men after coronary artery bypass graft surgery: 20-year experience from The Cleveland Clinic Foundation. Circulation 2000 0.85
29 Effectiveness of mevinolin on plasma lipoprotein concentrations in type II hyperlipoproteinemia. Am J Cardiol 1986 0.84
30 The Cincinnati Myocardial Infarction and Hormone Family Study: family resemblance for dehydroepiandrosterone sulfate in control and myocardial infarction families. Metabolism 1993 0.84
31 Total deficiency of plasma cholesteryl ester transfer protein in subjects homozygous and heterozygous for the intron 14 splicing defect. Biochem Biophys Res Commun 1990 0.83
32 Male-female differences in the relationship between obesity and lipids/lipoproteins. Int J Obes Relat Metab Disord 1996 0.82
33 The new food label, type of fat, and consumer choice. A pilot study. Arch Fam Med 1994 0.81
34 Dietary treatment and growth of hyperchylomicronemic children severely restricted in dietary fat. Am J Dis Child 1993 0.80
35 The conjoint trait of low high-density lipoprotein cholesterol and high triglycerides in adolescent black and white males. Metabolism 1998 0.80
36 Triglyceride and high-density lipoprotein cholesterol: predicting disorders in parents from their children. Pediatrics 1994 0.80
37 A novel test for the measurement of skin cholesterol. Clin Chem 2001 0.79
38 Comparison of cardiovascular risk and lipid profiles in patients undergoing aortic valve surgery versus those undergoing coronary artery bypass grafting. J Heart Valve Dis 2001 0.78
39 Sex hormones and lipoproteins in adolescent male offspring of parents with premature coronary heart disease and a control group. J Pediatr 1998 0.78
40 Lipoprotein(a) associated with coronary artery disease in older women: age and gender analysis. Atherosclerosis 2000 0.78
41 Normalization of plasma lipoprotein concentrations in patients with type II hyperlipoproteinemia by combined use of neomycin and niacin. Circulation 1984 0.77
42 Neomycin and plasma lipoproteins in type II hyperlipoproteinemia. Clin Pharmacol Ther 1984 0.77
43 Cincinnati myocardial infarction and hormone family study: family resemblance for testosterone in random and MI families. Am J Med Genet 1993 0.76
44 Estradiol and testosterone effects on lipids in black and white boys aged 10 to 15 years. Metabolism 2000 0.76
45 Risk factors for the development of premature cardiovascular disease. Adv Exp Med Biol 1985 0.76
46 Rational approach to pharmacologic reduction of cholesterol levels in children. J Pediatr 1996 0.75
47 The National Cholesterol Education Program pediatric guidelines: behavioral considerations. J Dev Behav Pediatr 1992 0.75
48 Effects of combination cholestyramine-neomycin treatment on plasma lipoprotein concentrations in type II hyperlipoproteinemia. Am J Cardiol 1985 0.75
49 Effect of premature myocardial infarction in men on the eating habits of spouses and offspring. J Am Diet Assoc 1994 0.75
50 A familial basis for the heterogeneity in coronary atherosclerotic disease. Atherosclerosis 1987 0.75
51 Effects of regular and extended-release gemfibrozil on plasma lipoproteins and apolipoproteins in hypercholesterolemic patients with decreased HDL cholesterol levels. Atherosclerosis 1996 0.75
52 Usefulness of providing physicians the results of risk factor assessments and treatment recommendations at discharge after coronary artery bypass grafting. Am J Cardiol 2000 0.75
53 Perspectives on cholesterol screening programs for children. J Pediatr 1991 0.75
54 A delayed-addition enzyme immunoassay for the relative cholesteryl ester transfer protein mass in patients with deficient plasma cholesteryl ester transfer activity. Clin Chim Acta 1990 0.75
55 Preventive cardiology: whose job is it? Who will pay for it? What is the best strategy? Cleve Clin J Med 1996 0.75
56 The psychological functioning of children with hypercholesterolemia and their families. A preliminary investigation. Clin Pediatr (Phila) 1993 0.75
57 Primary hyperlipidemia in a pediatric population: classification and effect of dietary treatment. Pediatrics 1993 0.75